| 000 | 01585 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513161242.0 | ||
| 264 | 0 | _c19990125 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/s0959-8049(98)00152-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBreistøl, K | |
| 245 | 0 | 0 |
_aThe antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cSep 1998 |
||
| 300 |
_a1602-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aProdrugs _xtherapeutic use |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 700 | 1 | _aHendriks, H R | |
| 700 | 1 | _aBerger, D P | |
| 700 | 1 | _aLangdon, S P | |
| 700 | 1 | _aFiebig, H H | |
| 700 | 1 | _aFodstad, O | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 34 _gno. 10 _gp. 1602-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(98)00152-x _zAvailable from publisher's website |
| 999 |
_c9855388 _d9855388 |
||